Sanaz Kamalinia, Robert G Josse, Patrick J Donio, Lindsay Leduc, Baiju R Shah, Sheldon W Tobe. Endocrinol Diabetes Metab 2019
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
100
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
Alex D Wright, Carole A Cull, Kenneth M Macleod, Rury R Holman. J Diabetes Complications 2006
Alex D Wright, Carole A Cull, Kenneth M Macleod, Rury R Holman. J Diabetes Complications 2006
100
Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry.
Diethelm Tschöpe, Peter Bramlage, Christiane Binz, Michael Krekler, Tanja Plate, Evelin Deeg, Anselm K Gitt. Cardiovasc Diabetol 2011
Diethelm Tschöpe, Peter Bramlage, Christiane Binz, Michael Krekler, Tanja Plate, Evelin Deeg, Anselm K Gitt. Cardiovasc Diabetol 2011
100
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Andreas Holstein, Claude Hammer, Michael Hahn, Nidhi-Su-Ann Kulamadayil, Peter Kovacs. Expert Opin Drug Saf 2010
Andreas Holstein, Claude Hammer, Michael Hahn, Nidhi-Su-Ann Kulamadayil, Peter Kovacs. Expert Opin Drug Saf 2010
100
A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
M R Burge, K Schmitz-Fiorentino, C Fischette, C R Qualls, D S Schade. JAMA 1998
M R Burge, K Schmitz-Fiorentino, C Fischette, C R Qualls, D S Schade. JAMA 1998
100
Sulfonylurea use associated with reduction in blood glucose levels during exercise stress testing.
Kaberi Dasgupta, Steven A Grover, Ilka Lowensteyn, Jean-Francois Yale, Deborah Da Costa, Elham Rahme. J Cardiopulm Rehabil 2005
Kaberi Dasgupta, Steven A Grover, Ilka Lowensteyn, Jean-Francois Yale, Deborah Da Costa, Elham Rahme. J Cardiopulm Rehabil 2005
100
Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia.
G E Sonnenberg, F W Kemmer, M Berger. Diabetologia 1990
G E Sonnenberg, F W Kemmer, M Berger. Diabetologia 1990
100
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.
Olivia J Phung, Jennifer M Scholle, Mehak Talwar, Craig I Coleman. JAMA 2010
Olivia J Phung, Jennifer M Scholle, Mehak Talwar, Craig I Coleman. JAMA 2010
100
Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study.
Antiopi Ntouva, Konstantinos A Toulis, Deepikshana Keerthy, Nicola J Adderley, Wasim Hanif, Rasiah Thayakaran, Krishna Gokhale, G Neil Thomas, Kamlesh Khunti, Abd A Tahrani,[...]. Eur J Endocrinol 2019
Antiopi Ntouva, Konstantinos A Toulis, Deepikshana Keerthy, Nicola J Adderley, Wasim Hanif, Rasiah Thayakaran, Krishna Gokhale, G Neil Thomas, Kamlesh Khunti, Abd A Tahrani,[...]. Eur J Endocrinol 2019
100
Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
S Franc, A Daoudi, A Pochat, M-H Petit, C Randazzo, C Petit, M Duclos, A Penfornis, E Pussard, D Not,[...]. Diabetes Obes Metab 2015
S Franc, A Daoudi, A Pochat, M-H Petit, C Randazzo, C Petit, M Duclos, A Penfornis, E Pussard, D Not,[...]. Diabetes Obes Metab 2015
100
Exercise-related hypoglycemia in diabetes mellitus.
Lisa M Younk, Maia Mikeladze, Donna Tate, Stephen N Davis. Expert Rev Endocrinol Metab 2011
Lisa M Younk, Maia Mikeladze, Donna Tate, Stephen N Davis. Expert Rev Endocrinol Metab 2011
100
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Daniel J Drucker, Michael A Nauck. Lancet 2006
Daniel J Drucker, Michael A Nauck. Lancet 2006
100
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
100
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
100
Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.
S-C Liu, Y-K Tu, M-N Chien, K-L Chien. Diabetes Obes Metab 2012
S-C Liu, Y-K Tu, M-N Chien, K-L Chien. Diabetes Obes Metab 2012
100
Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
Nanette C Schloot, Axel Haupt, Morten Schütt, Klaus Badenhoop, Markus Laimer, Claudia Nicolay, Matthew Reaney, Katharina Fink, Reinhard W Holl. Diabetes Metab Res Rev 2016
Nanette C Schloot, Axel Haupt, Morten Schütt, Klaus Badenhoop, Markus Laimer, Claudia Nicolay, Matthew Reaney, Katharina Fink, Reinhard W Holl. Diabetes Metab Res Rev 2016
100
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
100
Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment.
F W Kemmer, M Tacken, M Berger. Diabetes 1987
F W Kemmer, M Tacken, M Berger. Diabetes 1987
100
Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey.
M D Feher, P Grout, A Kennedy, R S Elkeles, R Touquet. Arch Emerg Med 1989
M D Feher, P Grout, A Kennedy, R S Elkeles, R Touquet. Arch Emerg Med 1989
100
Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: comparison of insulin glargine with NPH insulin as basal insulin supplement.
Ursula Plöckinger, Mendaha Topuz, Brigitte Riese, Thomas Reuter. Diabetes Res Clin Pract 2008
Ursula Plöckinger, Mendaha Topuz, Brigitte Riese, Thomas Reuter. Diabetes Res Clin Pract 2008
100
A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.
Mirna S Abd El Aziz, Melanie Kahle, Juris J Meier, Michael A Nauck. Diabetes Obes Metab 2017
Mirna S Abd El Aziz, Melanie Kahle, Juris J Meier, Michael A Nauck. Diabetes Obes Metab 2017
100
DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
A J Scheen. Diabetes Metab 2012
A J Scheen. Diabetes Metab 2012
100
Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
A Holstein, E-H Egberts. Exp Clin Endocrinol Diabetes 2003
A Holstein, E-H Egberts. Exp Clin Endocrinol Diabetes 2003
100
Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey.
Kamran Akram, Ulrik Pedersen-Bjergaard, Knut Borch-Johnsen, Birger Thorsteinsson. J Diabetes Complications 2006
Kamran Akram, Ulrik Pedersen-Bjergaard, Knut Borch-Johnsen, Birger Thorsteinsson. J Diabetes Complications 2006
100
Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.
Chloe L Edridge, Alison J Dunkley, Danielle H Bodicoat, Tanith C Rose, Laura J Gray, Melanie J Davies, Kamlesh Khunti. PLoS One 2015
Chloe L Edridge, Alison J Dunkley, Danielle H Bodicoat, Tanith C Rose, Laura J Gray, Melanie J Davies, Kamlesh Khunti. PLoS One 2015
100
Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs.
J E Signorovitch, D Macaulay, M Diener, Y Yan, E Q Wu, J-B Gruenberger, B M Frier. Diabetes Obes Metab 2013
J E Signorovitch, D Macaulay, M Diener, Y Yan, E Q Wu, J-B Gruenberger, B M Frier. Diabetes Obes Metab 2013
100
Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.
Muhammad A Abdul-Ghani, Luke Norton, Ralph A Defronzo. Endocr Rev 2011
Muhammad A Abdul-Ghani, Luke Norton, Ralph A Defronzo. Endocr Rev 2011
100
Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
100
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
M Nauck. Diabetes Obes Metab 2016
M Nauck. Diabetes Obes Metab 2016
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.